Boston Scientific to Buy Rest of Devoro Medical
September 21 2021 - 7:45AM
Dow Jones News
By Colin Kellaher
Boston Scientific Corp. on Tuesday said it agreed to buy the 84%
of Devoro Medical Inc. it doesn't already own for $269 million and
up to $67 million in potential clinical and regulatory milestone
payments.
The Marlborough, Mass., maker of medical devices, which has been
an investor in Devoro since 2019, said the acquisition adds the
WOLF Thrombectomy platform to its peripheral interventions
portfolio.
The company said it expects to complete the acquisition by the
end of the year.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
September 21, 2021 07:30 ET (11:30 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Apr 2023 to Apr 2024
